211 related articles for article (PubMed ID: 25565622)
1. The fiduciary relationship model for managing clinical genomic "incidental" findings.
Lázaro-Muñoz G
J Law Med Ethics; 2014; 42(4):576-89. PubMed ID: 25565622
[TBL] [Abstract][Full Text] [Related]
2. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
BMC Med Ethics; 2020 Jan; 21(1):9. PubMed ID: 32000764
[TBL] [Abstract][Full Text] [Related]
3. Disclosure of incidental findings from next-generation sequencing in pediatric genomic research.
Abdul-Karim R; Berkman BE; Wendler D; Rid A; Khan J; Badgett T; Hull SC
Pediatrics; 2013 Mar; 131(3):564-71. PubMed ID: 23400601
[TBL] [Abstract][Full Text] [Related]
4. Must Consent Be Informed? Patient rights, state authority, and the moral basis of the physician's duties of disclosure.
MacDougall DR
Kennedy Inst Ethics J; 2021; 31(3):247-270. PubMed ID: 34565744
[TBL] [Abstract][Full Text] [Related]
5. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
May T
J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
[TBL] [Abstract][Full Text] [Related]
6. Fiduciary disclosure of medical mistakes: the duty to promptly notify patients of adverse health care events.
Faunce TA; Bolsin SN
J Law Med; 2005 May; 12(4):478-82. PubMed ID: 15957590
[TBL] [Abstract][Full Text] [Related]
7. Incidental findings of uncertain significance: To know or not to know--that is not the question.
Hofmann B
BMC Med Ethics; 2016 Feb; 17():13. PubMed ID: 26873084
[TBL] [Abstract][Full Text] [Related]
8. Why genomics researchers are sometimes morally required to hunt for secondary findings.
Koplin JJ; Savulescu J; Vears DF
BMC Med Ethics; 2020 Jan; 21(1):11. PubMed ID: 32005225
[TBL] [Abstract][Full Text] [Related]
9. 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
Daack-Hirsch S; Driessnack M; Hanish A; Johnson VA; Shah LL; Simon CM; Williams JK
Clin Genet; 2013 Jul; 84(1):11-8. PubMed ID: 23590238
[TBL] [Abstract][Full Text] [Related]
10. Grappling with genomic incidental findings in the clinical realm.
Hull SC; Berkman BE
Chest; 2014 Feb; 145(2):226-230. PubMed ID: 24493507
[TBL] [Abstract][Full Text] [Related]
11. Attitudes of the general public towards the disclosure of individual research results and incidental findings from biobank genomic research in Australia.
Fleming J; Critchley C; Otlowski M; Stewart C; Kerridge I
Intern Med J; 2015 Dec; 45(12):1274-9. PubMed ID: 26390363
[TBL] [Abstract][Full Text] [Related]
12. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Evans BJ
Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
[TBL] [Abstract][Full Text] [Related]
13. Incidental findings: a common law approach.
Tovino SA
Account Res; 2008; 15(4):242-61. PubMed ID: 18972265
[TBL] [Abstract][Full Text] [Related]
14. Managing incidental genomic findings: legal obligations of clinicians.
Clayton EW; Haga S; Kuszler P; Bane E; Shutske K; Burke W
Genet Med; 2013 Aug; 15(8):624-9. PubMed ID: 23448723
[TBL] [Abstract][Full Text] [Related]
15. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
16. Critical social theory approach to disclosure of genomic incidental findings.
Bevan JL; Senn-Reeves JN; Inventor BR; Greiner SM; Mayer KM; Rivard MT; Hamilton RJ
Nurs Ethics; 2012 Nov; 19(6):819-28. PubMed ID: 22562957
[TBL] [Abstract][Full Text] [Related]
17. Secondary findings: How did we get here, and where are we going?
Ormond KE; O'Daniel JM; Kalia SS
J Genet Couns; 2019 Apr; 28(2):326-333. PubMed ID: 30821867
[TBL] [Abstract][Full Text] [Related]
18. Genomic test validation for incidental findings.
Park JY; Fortina P; Kricka LJ
Clin Chem; 2014 Feb; 60(2):292-3. PubMed ID: 23818443
[No Abstract] [Full Text] [Related]
19. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
20. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
